Dark background filled with a grid pattern of faint circles, scattered randomly with small dots in red, blue, and purple hues.
Home
Case studies
KYNEXIS THERAPEUTICS

2023

AWARD WINNING DESIGN

Kynexis Therapeutics Rebrand

Scroll

kynexis therapeutics

Differentiating a new approach to cognitive impairment in schizophrenia: Biotechs in this space must stand out in a crowded field while ensuring their story resonates beyond technical circles.

01

Research

02

Strategy

03

Design

04

Development

challenge

With multiple biotechs advancing potential schizophrenia treatments in 2023, Kynexis needed to differentiate its approach while introducing its leadership and scientific rationale to investors, partners, and the scientific community.

solution

SCIENT refreshed Kynexis’ brand with an updated logo, created a website that combined sophistication with a human touch, and launched targeted media and social campaigns that spotlighted its leadership and science, positioning the company as a credible, patient-focused player in cognitive impairment associated with schizophrenia (CIAS).

Black rectangular sign mounted on a light concrete wall displaying the kynexis logo with colorful circular design elements.

Brand Refresh

Kynexis logo with five colored circles in orange, black, and blue to the left of the word Kynexis on a light blue background.
Kynexis logo with stylized red, blue, and white circles to the left of the text on a dark background.
Abstract arrangement of five circles in orange, blue, and dark purple on a light blue background.
Kynexis logo with stylized red, blue, and white circles to the left of the text on a dark background.
Kynexis logo with five colored circles in orange, black, and blue to the left of the word Kynexis on a light blue background.
Kynexis logo with stylized red, blue, and white circles to the left of the text on a dark background.
Abstract arrangement of five circles in orange, blue, and dark purple on a light blue background.
Kynexis logo with stylized red, blue, and white circles to the left of the text on a dark background.
Kynexis logo with five colored circles in orange, black, and blue to the left of the word Kynexis on a light blue background.
Kynexis logo with stylized red, blue, and white circles to the left of the text on a dark background.
Abstract arrangement of five circles in orange, blue, and dark purple on a light blue background.
Kynexis logo with stylized red, blue, and white circles to the left of the text on a dark background.
Kynexis logo with five colored circles in orange, black, and blue to the left of the word Kynexis on a light blue background.
Kynexis logo with stylized red, blue, and white circles to the left of the text on a dark background.
Abstract arrangement of five circles in orange, blue, and dark purple on a light blue background.
Kynexis logo with stylized red, blue, and white circles to the left of the text on a dark background.

color palette

Midnight

RGB
CMYK
#170F25

Orange

RGB
CMYK
#FF5633

Sky

RGB
CMYK
#00B1FE

Grey

RGB
CMYK
#E2ECF4

Yellow

RGB
CMYK
#FFB400

Sun

RGB
CMYK
#FF8700

Dark Blue

RGB
CMYK
#024

Four smartphones displaying a website about Kynexis, showcasing brain disease therapeutics, management team bios, scientific approach, and news updates.

Mockups

Three posters with gradient backgrounds blending yellow, orange, and white, displaying text about precision therapeutics for brain diseases and cognitive impairment, with the Kynexis logo on the center poster.
Multiple dark business cards with blue and orange wave-like dotted patterns and Kynexis logo scattered on a dark background.

custom graphic

Diagram showing relationships between three psychiatric diseases, biomarkers and genetics, and three subtypes with corresponding colored dots and response profiles.
Vertical gradient background blending light blue, soft gray, vibrant coral, and dark blue-black colors.
Website homepage presenting Kynexis focus on precision therapeutics for brain diseases, with sections on purpose, approach, team members with photos, latest news, and contact information.